Advertisement

The Disease Burden of Mastectomy: Turkish Perspective and Impact on the Patient and Family

  • S. Özkan
  • M. Özkan
  • V. Özmen
  • Z. Armay
Reference work entry

Abstract:

Carcinoma of the breast is the most common site-specific cancer and is the leading cause of death from cancer in women with an estimated 1.15 million cases diagnosed in 2002. Breast cancer incidence and prevalence rates in Western Turkey in 1992 were 24.4/1000,000 and 0.3% respectively. Breast cancer incidence has increased in Turkey, and more than 15,000 new breast cancer cases were diagnosed in 2007. Breast cancer incidence and mortality show differences in different regions of Turkey depending on breast health awareness, diagnostic and therapeutic facilities, and other social, cultural and economic factors. The most common surgical treatment of breast cancer in Turkey is  modified radical mastectomy, which involves removal of the breast, pectoral muscles, and maxillary  lymph nodes. With its increasing prevalence and advanced stage at diagnosis, breast cancer treatment results in significant financial, social, psychological and psychosocial burden on the patients, families and the society. Burden of treatment of especially advanced breast cancer are tremendous, these are, morbidity, mortality, treatment expenses (hospitalization, outpatient care, and physician services, loss of productivity, surgical-systemic-radiation therapies, and psychological disorders of patients and their families). Intangible or psychosocial costs are pain and suffering from disease and its treatment that affect health and well being not reflected in the categories of direct or productivity costs. It is not possible to understand the breast cancer and  mastectomy experience independent from the specific culture. The Turkish history, culture, related values and traditions shape the experience of Turkish breast cancer patients. The burden of mastectomy duplicates when a thorough analysis is conducted with its various components that also greatly affect psychologically such as the reality of cancer, experiencing a surgery, and organ loss. This chapter aims to review the current Turkish literature on the various aspects of burden of breast cancer and mastectomy in comparison to the Western literature. The review clearly documents that an interdisciplinary approach that combines oncologic and psychiatric treatments is required for decreasing the burden of mastectomy.

Keywords

Breast Cancer Body Image Breast Reconstruction Breast Cancer Incidence Clinical Breast Examination 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:

ASR

age standardized rates

BCS

breast conservation surgery

BHA

breast health awareness

BMI

body mass index

CBE

clinical breast examination

DALY

disability adjusted life years

MRM

modified  radical mastectomy

SLNB

sentinel lymph node biopsy

TRAM

trans-rectus abdominis muscle

References

  1. Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS. (2007). World J Surg. 31(5): 1031–1040.PubMedCrossRefGoogle Scholar
  2. Baider L, Andritsch E, Goldzweig G. (2004). Psychosomatics. 45: 58–68.PubMedCrossRefGoogle Scholar
  3. Burcham J. (1997). “Breast Reconstruction: A Review of the Research and Patient Professional Resources.” National Breast Cancer Center, Sydney.Google Scholar
  4. Clugston P, Warren R. (2001). In: Glegg C (ed.) Intelligent Patient Guide to Breast Cancer: All you need to know to take an active part in your treatment, 3 ed. Gordon Soules Book Publishers Ltd., Vancouver, pp. 232–243.Google Scholar
  5. Cohen L, Thomas F, Hack J, et al. (2000). Ann Surg Oncol. 7(6): 427–434.PubMedCrossRefGoogle Scholar
  6. Cooper C, et al. (1989). Psychol Med. 19: 421–422.Google Scholar
  7. Curado MP, Edwards B, Shin HR, et al. (ed.) (2007). “Cancer Incidence in Five Continents”, vol. IX. International Agency for Research on Cancer, Lyon, France. IARC scientific publications no. 160. http://www-dep.iarc.fr/. Accessed 27 Dec 2007.
  8. Dean C. (1987). J. Psychosom Res. 31: 385–392.PubMedCrossRefGoogle Scholar
  9. Fidaner C, Eser SY, Parkin DM. (2001). Eur J Cancer. 37: 83–92.PubMedCrossRefGoogle Scholar
  10. Friedman PE, Baer DV, Nelson M, Lane FE, Smith D, Dworkin RJ. (1988). Psychosom Med. 50: 529–540.PubMedGoogle Scholar
  11. Ganz PA, et al. (1992). Cancer. 69: 1729–1738.PubMedCrossRefGoogle Scholar
  12. Geer S, et al. (1990). Lancet. 1: 49–50.CrossRefGoogle Scholar
  13. Goldberg J, Scott R, Davidson P, et al. (1992). Eur J Surg Oncol.18: 327–331.PubMedGoogle Scholar
  14. Hankey BF, Miller B, Curtis R, et al. (1994). J Natl Cancer Inst Monogr. 16: 7–14.PubMedGoogle Scholar
  15. Hann D, Baker F, Denniston M, Gesme D, Reding D, Flynn T, Kennedy J, Kieltyka RL. (2002). J Psychosom Res. 52: 279–283.PubMedCrossRefGoogle Scholar
  16. Hocaoğlu Ç, Kandemir G, Civil F. (2007). Meme Sağliği Dergsi. 3(3): 163–166.Google Scholar
  17. Juon HS, Choi Y, Kim MT. (2000). Cancer Detect Prev. 24: 589–601.PubMedGoogle Scholar
  18. Karanlik H, Özmen V, et al. (2006). J Breast Health (Meme Sağliği Dergisi). 2: 89–95. (www.memesagligi.org)
  19. Liede A, Narod SA. (2002). Hum Mutat. 20: 413–424.PubMedCrossRefGoogle Scholar
  20. Nahcivan NO, Seckingil S. (2007). Oncol Nurs Forum. 34(2): 425–432.PubMedCrossRefGoogle Scholar
  21. National Disease Burden and Cost-Effectiveness Project. (2004). “T.C. Sağlık Bakanlığı Refik Saydam Hıfzıssıhha Merkezi Başkanlığı Hıfzıssıhha Mektebi Müdürlüğü, Başkent Üniversitesi, Ulusal Hastalık Yükü Ve Maliyet-Etkililik Projesi.”Google Scholar
  22. Northouse L, Teplin T, Mood D, Oberst M. (1998). Psychooncology. 7(1): 37–48.PubMedCrossRefGoogle Scholar
  23. Noyan A, Sertöz OO, Elbi H, Kayar R, Yýlmaz R. (2006). Int J Psychiatry Med. 36(3): 299–313.PubMedCrossRefGoogle Scholar
  24. Nystrom L, Rutqvist LE, Wall S, et al. (1993). Lancet. 341(8851): 973–978.PubMedCrossRefGoogle Scholar
  25. Özkan S. (1993). “İstanbul Tıp Fakültesi kliniklerinde psikiyatrik tıp hizmetlerinin gelişimi ve liyezon psikiyatrisi modelinin uygulanması”, İ.Ü. İ.T.F. Psikiyatri ABD Profesörlük taktim tezi, İstanbul.Google Scholar
  26. Özkan S, Turgay M. (1992). Nöro Psikiyatri Arşivi. 29(4): 207–215.Google Scholar
  27. Ozmen V. (2007). J Breast Health. 3: 48–50.Google Scholar
  28. Ozmen V. (2008a). J Breast Health (Meme Sağlığı Dergisi). 4: 6–12. (www.memesagligi.org)
  29. Ozmen V. (2008b). “Breast cancer screening and registration programms in Turkey”. In: Tuncer M (ed.) Cancer Control in Turkey. Health Ministry Publication Number 740, Onur Press, Ankara, pp. 335–343.Google Scholar
  30. Ozmen V, Cabioglu N, Gulluoglu B, Özcinar B. (2007). Survey on a pilot mammographic screening in Bahcesehir, Istanbul, Turkey. Paper Presented at The Breast Health Global Initiative Consensus Conference,1–4 Oct 2007, Budapest, Hungary. http://www.fhcrc.org/science/phs/bhgi/
  31. Parkin DM, Bray F, Ferlay J, et al. (2005). CA Cancer J Clin. 55(2): 74–108.PubMedCrossRefGoogle Scholar
  32. Reither AM, Stoudemire A. (1987). In: Hackett TP, Cassen NH (ed.) Handbook of General Hospital Psychiatry. Year Book Medical publishers Inc., Chicago, pp. 423–451.Google Scholar
  33. Robson M. (2004). Clin Breast Cancer. 5: 260–268; discussion 269–271.PubMedCrossRefGoogle Scholar
  34. Rowland JH, Holland JC. (1990). In: Holland JC, Rowland JH (ed.) Handbook of Psychooncology. Psychological Care of The Patient With Cancer. Oxford University Press, New York, pp. 188–207.Google Scholar
  35. Sant M, Allemani C, Berrino F, et al. (2004). Cancer. 100(4): 715–722.PubMedCrossRefGoogle Scholar
  36. Sertöz O, Elbi HM, Noyan A, Alper M, Kapkac M. (2004). Türk Psikiyatri Dergisi. 15(4): pp. 264–275.Google Scholar
  37. Shaw de Paredes E, Marsteller LP, Eden BV. (1990). Radiology. 177: 117–119.PubMedGoogle Scholar
  38. Smith RA, Duffy SW, Gabe R, et al. (2004). Radiol Clin North Am. 42(5): 793–806.PubMedCrossRefGoogle Scholar
  39. Tuncer M. (2008). “Significance of cancer in Turkey, the burden of disease, and cancer control policies”. In: Tuncer M (ed.) Cancer Control in Turkey. Health Ministry Publication No. 740, Onur Press, Ankara, pp. 5–9.Google Scholar
  40. Weir HK, Thun MJ, Hankey BF, et al. (2003). J Natl Cancer Inst. 95(17): 1276–1299.PubMedGoogle Scholar
  41. Wellisch D, et al. (1989). Psychosomatics. 30(4): 365–373.PubMedGoogle Scholar
  42. Yazihan N, Hakan H. (2006). Breast cancer in Turkey: Economic Efficiency and Cost Effectiveness, Cancer Control in Turkey, Cancer Control in Turkey. Health Ministry Publication, Number 740, Onur Press, Ankara.Google Scholar
  43. Yİlmazer N, Aydİner A, Özkan S, Aslay I, Bilge N. (1994). Support care cancer. 2(4): 238–241.PubMedCrossRefGoogle Scholar
  44. Yucel A, Değirmenci B, Acar H, Ellidokuz H, Albayrak R, Haktanir A. (2004). Knowledge about Breast Cancer and Mammography in Breast Cancer Screening among Women Awaiting Mammography. Turk. J. Med Sci., 35: 35–42.Google Scholar
  45. Yücel A, Değirmenci B, Acar M, Ellidozkuz H, Albayrak R. (2005). Turk J Med Sci. 35: 35–42.Google Scholar

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • S. Özkan
    • 1
  • M. Özkan
    • 1
  • V. Özmen
    • 1
  • Z. Armay
    • 1
  1. 1.Department of Consultation Liaison PsychiatryUniversity of IstanbulÇapaTurkey

Personalised recommendations